Development and application of a layered risk management framework for a clinical biochemistry laboratory in accordance with ISO 15189:2022
Аннотация
Laboratory errors across the total testing process pose significant risks to patient safety, with downstream implications for diagnostic accuracy, particularly in high-workload clinical biochemistry laboratories. The revised International Organization for Standardization (ISO) 15189:2022 standard explicitly mandates risk-based thinking as core operational requirement; however, structured frameworks translating this mandate into practice within NABL-accredited Indian laboratories remain limited. This study aimed to develop and apply a structured risk assessment, Layered Risk Management Framework (LRMF) in a National Accreditation Board for Testing and Calibration Laboratories (NABL)-accredited tertiary care clinical biochemistry laboratory, operationalizing ISO 15189:2022 risk management principles across the total testing process. Following Institutional Ethics Committee approval, a multidisciplinary risk management group conducted comprehensive process mapping of the laboratory workflow from specimen receipt to report release. Risk identification was performed through focused group discussions and retrospective review of quality records. Each risk was quantified using a Risk Priority Number (RPN) derived from likelihood, severity, and detectability scores, classified into five actionable tiers (X1–X5), and causally mapped using the 6 M framework. Of the 103 identified risks, the pre-examination phase contributed the greatest burden (38 %), with human factors dominating causal attribution across all phases (72 %). Twenty-one high-priority risks were escalated for structured corrective and preventive action, including one critical Tier X5 error and two serious Tier X4 errors, all arising from pre-examination human failures involving specimen labeling and patient identification. Responsible personnel, timelines, and residual risk expectations were formally assigned for every prioritized risk. The LRMF demonstrated practical utility as a systematic, reproducible, and accreditation-aligned tool for embedding proactive risk governance within clinical biochemistry laboratory, with applicability across comparable NABL-accredited settings.